STOCK TITAN

Blackstone entities (NASDAQ: MDLN) report 153.3M Medline shares, 16.5% stake

(Neutral)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Medline Inc. received an updated ownership report from multiple Blackstone-affiliated entities and Stephen A. Schwarzman regarding holdings of Class A common stock. As of June 30, 2026, they may be deemed to beneficially own an aggregate of 153,327,675 shares of Class A common stock, representing 16.5% of the class, based on 875,111,752 shares outstanding as of May 28, 2026.

The stake is held through several Delaware partnerships and limited liability companies, including BX Mozart ML-2 Holdco L.P., BX Mozart ML-1 Holdco L.P., and related “Mozart” aggregators. Part of the position consists of Common Units of Medline Holdings, LP paired with an equal number of Class B common shares, which have no economic value but one vote per share and are exchangeable into Class A shares on a one-for-one basis under a perpetual exchange agreement. The reporting persons state that their ownership may be deemed beneficial and expressly disclaim being a group or ultimate beneficial owners beyond the directly holding entities.

Positive

  • None.

Negative

  • None.
Aggregate beneficial ownership 153,327,675 shares Class A common stock deemed beneficially owned as of June 30, 2026
Stake percentage 16.5% Percent of Medline Class A shares deemed beneficially owned
Shares outstanding 875,111,752 shares Medline Class A shares outstanding as of May 28, 2026
BX Mozart ML-2 Holdco L.P. 89,537,913 shares; 10.2% Directly held Class A shares and corresponding ownership percentage
BX Mozart ML-1 Holdco L.P. 10,185 shares + 44,770,628 Common Units; 4.9% Direct Class A plus Common Units and related ownership percentage
Mozart Aggregator II UNLV Holdco L.P. 10,250,904 shares; 1.2% Direct Class A holdings and ownership percentage
Mozart Aggregator II LP 1,990,467 shares; 10.5% Class A holdings and reported percent for Mozart Aggregator II
Blackstone Management Associates VIII L.P. 101,779,284 shares; 11.0% Shares and percentage deemed beneficially owned
beneficially own regulatory
"may be deemed to beneficially own an aggregate of 153,327,675 shares"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
Common Units financial
"44,770,628 Common Units of Medline Holdings, LP (each a "Common Unit")"
Common units are the basic ownership stakes in a company, limited partnership, or trust that function like common stock: they give holders a claim on profits and often voting rights. Think of them as the ordinary seats at a table—the most directly affected by the business’s success or failure, so they typically offer higher upside but carry greater risk than preferred claims or creditors, which matters to investors evaluating potential return and safety.
Class B Common Stock financial
"an equal number of shares of Class B common stock, par value $0.0001 per share"
A class B common stock is one of multiple types of a company’s ordinary shares that carries specific rights—often different voting power or dividend priority—compared with other classes. For investors it matters because those differences affect how much influence you have over company decisions, the income you might receive, and how freely the shares trade; think of it like owning a car with different keys: some keys let you start the engine and open the trunk, others only unlock the door.
exchange agreement regulatory
"Pursuant to the terms of an exchange agreement, dated as of December 16, 2025"
A written deal in which two parties agree to swap assets, securities or obligations under set terms—think of it as a formal swap or trade contract. For investors it matters because such agreements can change who owns what, alter a company’s capital structure, affect future cash flows or dilute existing shares, and therefore influence value and risk in a straightforward, contract-driven way.
Section 13(d) regulatory
"for purposes of Section 13(d) of the Securities Exchange Act of 1934"
group regulatory
"should not be construed to be an admission that any members are members of a "group""

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

How much of Medline Inc. (MDLN) does Blackstone report owning in this Schedule 13G/A?

The reporting persons state they may be deemed to beneficially own 153,327,675 shares of Medline Class A common stock, representing 16.5% of the class, based on 875,111,752 shares outstanding as of May 28, 2026.

What percentage of Medline Inc. (MDLN) does each key Blackstone holder report?

Selected holders report: BX Mozart ML-2 Holdco L.P. 10.2%, BX Mozart ML-1 Holdco L.P. 4.9%, Mozart Aggregator II 10.5%, Blackstone Management Associates VIII L.P. 11.0%, and Blackstone Inc. and affiliates (including Stephen A. Schwarzman) 16.5% each.

What are the main direct Medline (MDLN) holdings of the Blackstone entities?

BX Mozart ML-2 Holdco L.P. directly holds 89,537,913 Class A shares. BX Mozart ML-1 Holdco L.P. holds 10,185 Class A shares and 44,770,628 Common Units. Mozart Aggregator II UNLV Holdco L.P. holds 10,250,904 Class A shares, and Mozart Aggregator II LP holds 1,990,467 Class A shares.

Do the Blackstone reporting persons admit being a group for Medline (MDLN) under Section 13(d)?

They state the ownership could be deemed beneficial but expressly disclaim beneficial ownership beyond the direct holders and state that the report should not be construed as an admission that they are members of a “group” under Sections 13(d) and 13(g).





58507V107

(CUSIP Number)
06/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



BX Mozart ML-2 Holdco L.P.
Signature:/s/ Robert Brooks
Name/Title:By: BX Mozart ML-2 Holdco GP L.L.C., its GP, By: Robert Brooks, Vice President
Date:08/07/2026
BX Mozart ML-1 Holdco L.P.
Signature:/s/ Robert Brooks
Name/Title:By: BX Mozart ML-1 Holdco GP L.L.C., its GP, By: Robert Brooks, Vice President
Date:08/07/2026
Mozart Aggregator II UNLV Holdco L.P.
Signature:/s/ Robert Brooks
Name/Title:By: Blackstone Management Associates VIII L.P., its GP, By: BMA VIII L.L.C., its GP, By: Robert Brooks, Authorized Signatory
Date:08/07/2026
Mozart Aggregator UNLV Holdco L.P.
Signature:/s/ Robert Brooks
Name/Title:By: BCP 8 Holdings Mozart Manager L.L.C., its general partner, By: BMA VIII L.L.C., its MM, By: Robert Brooks, Authorized Signatory
Date:08/07/2026
Mozart Aggregator II LP
Signature:/s/ Robert Brooks
Name/Title:By: Blackstone Management Associates VIII L.P., its GP, By: BMA VIII L.L.C., its GP, By: Robert Brooks, Authorized Signatory
Date:08/07/2026
BX Mozart ML-2 Holdco GP L.L.C.
Signature:/s/ Robert Brooks
Name/Title:Robert Brooks, Vice President
Date:08/07/2026
BX Mozart ML-1 Holdco GP L.L.C.
Signature:/s/ Robert Brooks
Name/Title:Robert Brooks, Vice President
Date:08/07/2026
BCP Mozart Aggregator L.P.
Signature:/s/ Robert Brooks
Name/Title:By: BCP 8 Holdings Mozart Manager L.L.C., its general partner, By: BMA VIII L.L.C., its managing member, By: Robert Brooks, Authorized Signatory
Date:08/07/2026
Blackstone Management Associates VIII L.P.
Signature:/s/ Christopher Striano
Name/Title:By: BMA VIII L.L.C., its general partner, By: Robert Brooks, Authorized Signatory
Date:08/07/2026
BCP 8 Holdings Mozart Manager L.L.C.
Signature:/s/ Christopher Striano
Name/Title:By: BMA VIII L.L.C., its managing member, By: Christopher Striano, Senior Managing Director and Chief Operating Officer of Global Finance
Date:08/07/2026
BMA VIII L.L.C.
Signature:/s/ Christopher Striano
Name/Title:Christopher Striano, Senior Managing Director and Chief Operating Officer of Global Finance
Date:08/07/2026
Blackstone Holdings II L.P.
Signature:/s/ Victoria Portnoy
Name/Title:By: Blackstone Holdings I/II GP L.L.C., its general partner, By: Victoria Portnoy, Managing Director - Assistant Secretary
Date:08/07/2026
Blackstone Holdings I/II GP L.L.C.
Signature:/s/ Victoria Portnoy
Name/Title:Victoria Portnoy, Managing Director - Assistant Secretary
Date:08/07/2026
Blackstone Inc.
Signature:/s/ Victoria Portnoy
Name/Title:Victoria Portnoy, Managing Director - Assistant Secretary
Date:08/07/2026
Blackstone Group Management L.L.C.
Signature:/s/ Victoria Portnoy
Name/Title:Victoria Portnoy, Managing Director - Assistant Secretary
Date:08/07/2026
Stephen A. Schwarzman
Signature:/s/ Stephen A. Schwarzman
Name/Title:Stephen A. Schwarzman
Date:08/07/2026